@article{TLCR71044,
author = {Zihua Zou and Yangchun Gu and Li Liang and Xuezhi Hao and Chengjuan Fan and Tao Xin and Songchen Zhao and Ziling Liu and Ye Guo and Kewei Ma and Haojing Li and Cuiying Zhang and Li Shan and Yan Zhang and Guilan Dong and Yumei Peng and Fangfang Shen and Xia Song and Petros Christopoulos and Anthonie J. van der Wekken and Katsuhiro Okuda and Simon Ekman and Puyuan Xing and Junling Li},
title = {Alectinib as first-line treatment for advanced ALK-positive non-small cell lung cancer in the real-world setting: preliminary analysis in a Chinese cohort},
journal = {Translational Lung Cancer Research},
volume = {11},
number = {12},
year = {2022},
keywords = {},
abstract = {},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/71044}
}